UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer

Cancer, 2017-05, Vol.123 (9), p.1566-1575

2017

Volltextzugriff (PDF)

An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2021-01, Vol.27 (1), p.330-341

2021

Volltextzugriff (PDF)

Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2017-08, Vol.98 (5), p.1002-1011

2017

Volltextzugriff (PDF)

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

The Lancet (British edition), 2019-11, Vol.394 (10212), p.1915-1928

2019

Volltextzugriff (PDF)

Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study

International journal of radiation oncology, biology, physics, 2012-07, Vol.83 (3), p.878-886

2012

Volltextzugriff (PDF)

Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3601-3609

2017

Volltextzugriff (PDF)

Long‐term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status

The Laryngoscope, 2019-11, Vol.129 (11), p.2506-2513

2019

Volltextzugriff (PDF)

Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review

JAMA otolaryngology-- head & neck surgery, 2019-02, Vol.145 (2), p.166

2019

Volltextzugriff (PDF)

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

The lancet oncology, 2017-09, Vol.18 (9), p.1221-1237

2017

Volltextzugriff (PDF)

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Annals of oncology, 2017-07, Vol.28 (7), p.1605-1611

2017

Volltextzugriff (PDF)

Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab

Journal of clinical oncology, 2016-04, Vol.34 (12), p.1300-1308

2016

Volltextzugriff (PDF)

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer

Journal of clinical oncology, 2017-12, Vol.35 (36), p.4057-4065

2017

Volltextzugriff (PDF)

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

Clinical cancer research, 2015-02, Vol.21 (3), p.632-641

2015

Volltextzugriff (PDF)

The impact of radiation treatment time on survival in patients with head and neck cancer

International journal of radiation oncology, biology, physics, 2016-12, Vol.96 (5), p.967-975

2016

Volltextzugriff (PDF)

Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer

European journal of cancer (1990), 2015-12, Vol.51 (18), p.2777-2784

2015

Volltextzugriff (PDF)

Hyperbaric oxygenation for tumour sensitisation to radiotherapy

Cochrane database of systematic reviews, 2018-04, Vol.4 (7), p.CD005007

2018

Volltextzugriff (PDF)

Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States

Journal of clinical oncology, 2016-01, Vol.34 (2), p.169-178

2016

Volltextzugriff (PDF)

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity

Journal of clinical oncology, 2014-12, Vol.32 (34), p.3858-3867

2014

Volltextzugriff (PDF)

Distant metastases in head and neck cancer

Head & neck, 2017-09, Vol.39 (9), p.1733-1743

2017

Volltextzugriff (PDF)

Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2014-05, Vol.89 (1), p.13-20

2014

Volltextzugriff (PDF)

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

Clinical cancer research, 2022-02, Vol.28 (3), p.468-478

2022

Volltextzugriff (PDF)

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522

Journal of clinical oncology, 2014-09, Vol.32 (27), p.2940-2950

2014

Volltextzugriff (PDF)

Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma

Head & neck, 2016-07, Vol.38 (7), p.1074-1084

2016

Volltextzugriff (PDF)

Five‐year relative survival for human papillomavirus‐associated cancer sites

Cancer, 2018-01, Vol.124 (1), p.203-211

2018

Volltextzugriff (PDF)

1 – 25 von 7.563

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.928)
Mit Volltextzugriff
(6.416)

Publikationsform

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(7.500)
Science & Technology
(6.658)
Life Sciences & Biomedicine
(6.463)
Male
(5.925)
Female
(5.883)
Middle Aged
(5.297)
Aged
(4.718)
Head And Neck Neoplasms - Mortality
(4.684)
Adult
(3.986)
Carcinoma, Squamous Cell - Mortality
(3.136)
Oncology
(2.923)
Prognosis
(2.877)
Otorhinolaryngology
(2.837)
Retrospective Studies
(2.539)
Head And Neck Neoplasms - Pathology
(2.432)
Surgery
(2.304)
Aged, 80 And Over
(2.272)
Biological And Medical Sciences
(2.072)
Medical Sciences
(2.070)
Tumors
(2.067)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(7.525)
Lippincott Journal Package
(3.672)
Ingenta
(3.334)
EZB Electronic Journals Library
(2.407)
Wiley Online Library - AutoHoldings Journals
(2.138)
Wiley Online Library Full Collection 2018
(1.788)
Elsevier ScienceDirect Journals Complete
(1.415)
Single Journals
(1.239)
Springer Online Journals
(1.187)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.106)
IngentaConnect Journals
(1.100)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(816)
SAGE Journals
(343)
HEAL-Link subscriptions: Springer Book Series
(258)
Taylor & Francis Journals
(247)
Taylor & Francis
(226)
Taylor & Francis Online
(216)
Nature Journals Online
(139)
Nexis Uni (LexisNexis)
(119)
PBSC : Psychology and Behavioral Sciences Collection - Journals
(118)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Head & Neck
(811)
The Laryngoscope
(321)
International Journal Of Radiation Oncology, Biology, Physics
(310)
European Archives Of Oto-Rhino-Laryngology
(261)
Cancer
(254)
Archives Of Otolaryngology--Head & Neck Surgery
(208)
Oral Oncology
(154)
Otolaryngology-Head And Neck Surgery
(145)
Plos One
(136)
The American Journal Of Surgery
(118)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(38)

Menü

Weitere Dienste

Einstellungen

The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer

An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma

Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study

Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer

Long‐term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status

Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

The impact of radiation treatment time on survival in patients with head and neck cancer

Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer

Hyperbaric oxygenation for tumour sensitisation to radiotherapy

Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity

Distant metastases in head and neck cancer

Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522

Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma

Five‐year relative survival for human papillomavirus‐associated cancer sites

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

Suchergebnisse filtern